Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
BMC Pulm Med ; 21(1): 43, 2021 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-33509141

RESUMEN

BACKGROUND: Besides the clinical benefit of crizotinib in ALK-rearranged metastatic non-small cell lung cancer (NSCLC), concerns about its hepatotoxicity have arisen. It is not clear whether this is a drug class side effect or if the use of other selective ALKs inhibitors is safe after this serious adverse event. While evidence from clinical trials is scarce, reports of treatment after crizotinib-induces hepatitis may add to clinical decision. CASE PRESENTATION: Herein, we report a case of acute hepatitis induced by crizotinib in a 32-years-old female diagnosed with metastatic NSCLC, harboring the ALK-rearrangement. After 60 days of crizotinib therapy, the patient presented with acute hepatitis, diagnosed after investigation of non-specific symptoms, such as nausea and fatigue. Serum aspartate aminotransferase and alanine aminotransferase levels had increased from baseline to 3010 IU/L and 9145 IU/L, respectively. Total bilirubin increased up to 7.91 mg/dL, but she did not develop liver failure. After crizotinib discontinuation, a gradual hepatic function recovery occurred. Unfortunately, during the period without specific oncology treatment, her disease showed an unequivocal progression. Therefore, she started on alectinib with great response, and no liver function alteration recurred. CONCLUSIONS: This case suggests that alectinib, even belonging to the same drug class, could be used as an alternative agent when crizotinib is the etiology of liver damage, but more robust evidence has awaited.


Asunto(s)
Carbazoles/uso terapéutico , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Crizotinib/efectos adversos , Hepatitis/etiología , Neoplasias Pulmonares/tratamiento farmacológico , Piperidinas/uso terapéutico , Adulto , Bilirrubina/sangre , Carcinoma de Pulmón de Células no Pequeñas/patología , Femenino , Hepatitis/tratamiento farmacológico , Humanos , Hígado/efectos de los fármacos , Hígado/fisiopatología , Neoplasias Pulmonares/patología , Inhibidores de Proteínas Quinasas/uso terapéutico , Resultado del Tratamiento
2.
Rev Col Bras Cir ; 42(2): 75-80, 2015.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-26176672

RESUMEN

OBJECTIVE: To evaluate the importance of flexible bronchoscopy in tracheostomy patients in the process of decannulation to assess the incidence and types of laryngotracheal injury and compare the presence of such lesions with clinical criteria used for decannulation. METHODS: We studied 51 tracheostomized patients aged between 19 and 87 years, with tracheal stent for a mean of 46 ± 28 days and with clinical criteria for decannulation. They were submitted to tracheostomy tube occlusion tolerance testfor 24 hours, and then to flexible bronchoscopy. We described and classified the diagnosed laryngotracheal changes. We compared the clinical criteria for decannulation indication with the bronchoscopy-diagnosed laryngotracheal injuries that contraindicated decannulation. We identified the factors that could interfere in decannulation and evaluated the importance of bronchoscopy as part of the process. RESULTS: Forty (80.4%) patients had laryngotracheal alterations. Of the 40 patients considered clinically fit to decannulation, eight (20%) (p = 0.0007) presented with laryngotracheal injuries at bronchoscopy that contraindicated the procedure. The most frequent laryngeal alteration was vocal cords lesion, in 15 (29%) individuals, and granuloma, the most prevalent tracheal lesion, in 14 (27.5%) patients. CONCLUSION: flexible bronchoscopy showed a large number of laryngotracheal injuries, the most frequent being the vocal cords injury in the larynx and the granuloma in the trachea, which contributed to increase the decannulation procedure safety.


Asunto(s)
Broncoscopía , Laringe/lesiones , Tráquea/lesiones , Traqueostomía , Adulto , Anciano , Anciano de 80 o más Años , Remoción de Dispositivos , Humanos , Intubación Intratraqueal , Persona de Mediana Edad , Estudios Prospectivos , Heridas y Lesiones/diagnóstico por imagen , Adulto Joven
3.
Rev. Col. Bras. Cir ; 42(2): 75-80, Mar-Apr/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-752119

RESUMEN

OBJECTIVE: To evaluate the importance of flexible bronchoscopy in tracheostomy patients in the process of decannulation to assess the incidence and types of laryngotracheal injury and compare the presence of such lesions with clinical criteria used for decannulation. METHODS: We studied 51 tracheostomized patients aged between 19 and 87 years, with tracheal stent for a mean of 46 ± 28 days and with clinical criteria for decannulation. They were submitted to tracheostomy tube occlusion tolerance testfor 24 hours, and then to flexible bronchoscopy. We described and classified the diagnosed laryngotracheal changes. We compared the clinical criteria for decannulation indication with the bronchoscopy-diagnosed laryngotracheal injuries that contraindicated decannulation. We identified the factors that could interfere in decannulation and evaluated the importance of bronchoscopy as part of the process. RESULTS: Forty (80.4%) patients had laryngotracheal alterations. Of the 40 patients considered clinically fit to decannulation, eight (20%) (p = 0.0007) presented with laryngotracheal injuries at bronchoscopy that contraindicated the procedure. The most frequent laryngeal alteration was vocal cords lesion, in 15 (29%) individuals, and granuloma, the most prevalent tracheal lesion, in 14 (27.5%) patients. CONCLUSION: flexible bronchoscopy showed a large number of laryngotracheal injuries, the most frequent being the vocal cords injury in the larynx and the granuloma in the trachea, which contributed to increase the decannulation procedure safety.


OBJETIVO: Avaliar a importância do emprego, da broncoscopia flexível nos pacientes traqueostomizados em vias de decanulação para conhecer a incidência e os tipos de lesões laringotraqueais e comparar a presença destas lesões com os critérios clínicos utilizados para a decanulação. MÉTODOS: foram estudados 51 pacientes, com idade entre 19 e 87 anos, traquestomizados, com critérios clínicos de decanulação e com tempo médio de órtese traqueal de 46 ± 28 dias. Foram submetidos ao teste de tolerância à oclusão da cânula de traqueostomia por 24 horas, seguida da realização da broncoscopia flexível. As alterações laringotraqueais diagnosticadas foram descritas e classificadas. Comparou-se a indicação de decanulação por critérios clínicos com o diagnóstico de lesões laringotraqueais à broncoscopia que contraindicavam a decanulação. Identificaram-se os fatores que poderiam interferir na decanulação e avaliou-se a importância da broncoscopia como parte do processo. RESULTADOS: Apresentaram alterações laringotraqueais, 40 pacientes (80,4%). Dos 40 pacientes considerados clinicamente aptos à decanulação, oito (20%) (p=0,0007) apresentaram lesões laringotraqueais à broncoscopia que contraindicaram o procedimento. A alteração laríngea mais frequente foi lesão de pregas vocais em 15 (29%) e o granuloma, a lesão traqueal mais prevalente em 14 (27,5%) pacientes. CONCLUSÃO: a broncoscopia flexível evidenciou um número elevado de lesões laringotraqueais, sendo mais prevalentes a lesão de pregas vocais na laringe e o granuloma na traqueia, que contribuiu para aumentar a segurança do procedimento de decanulação.


Asunto(s)
Humanos , Broncoscopía , Intubación Intratraqueal , Enfermedades de la Tráquea , Traqueomalacia , Traqueostomía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA